Ranolazine Loading to Prevent PCI-induced Myocardial Injury

NCT01491061 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

University of Roma La Sapienza